Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
- Report Highlights
Chapter 3 Market Overview and Definitions
- Overview
- Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Role of Insulin
- Diabetes Treatment
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Challenges
Chapter 4 Market Breakdown by Region
- Market Overview and Discussion
- Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 5 Market Breakdown by Onset Time
- Market Overview and Discussion
- Long-Acting Insulin
- Rapid-Acting Insulin
- Intermediate-Acting Insulin
- Short-Acting Insulin
- Market Size and Forecast
- Long-Acting Insulin Pens
- Intermediate-Acting Insulin Pens
- Short-Acting Insulin Pens
- Rapid-Acting Insulin Pens
Chapter 6 Market Breakdown by End User
- Market Overview
- Hospitals
- Pharmacies
- Market Size and Forecast
- Global Insulin Pen End-Users Market
- North American End-User Market
- European End-User Market
- Asia-Pacific End-User Market
- Rest of the World's End-User Market
Chapter 7 ESG Development
- Introduction
- Environmental
- Social
- Governance
- Case Study
- Novo Nordisk A/S
- Concluding Remarks
Chapter 8 Competitive Landscape
- Overview and Industry Scenario
- Company Shares
- Recent Key Developments
Chapter 9 Company Profiles
- AstraZeneca
- Biocon
- Boehringer Ingelheim International Gmbh
- Eli Lilly And Co.
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
- Novartis Ag
- Novo Nordisk A/S
- Sanofi
- Viatris Inc.
Chapter 10 Appendix: Acronyms
List of Tables
Summary Table: Global Market for Insulin Pens, by Type, Through 2028
Table 1: Global Insulin Pens Market Drivers
Table 2: Global Insulin Pens Market Restraints
Table 3: Global Insulin Pens Market Challenges
Table 4: Global Market for Insulin Pens, by Region, Through 2028
Table 5: North American Market for Insulin Pens, by Type, Through 2028
Table 6: European Market for Insulin Pens, by Type, Through 2028
Table 7: Asia-Pacific Market for Insulin Pens, by Type, Through 2028
Table 8: Rest of the World Market for Insulin Pens, by Type, Through 2028
Table 9: Insulin Type and Features
Table 10: Leading Insulin Products and Their Types
Table 11: Global Market for Insulin Pens, by Onset Time, Through 2028
Table 12: Global Market for Long-Acting Insulin Pens, by Region, Through 2028
Table 13: Global Market for Intermediate-Acting Insulin Pens, by Region, Through 2028
Table 14: Global Market for Short- Acting Insulin Pens, by Region, Through 2028
Table 15: Global Market for Rapid-Acting Insulin Pens, by Region, Through 2028
Table 16: Global Market for Insulin Pens for Hospitals, by Region, Through 2028
Table 17: Global Market for Insulin Pens for Pharmacies, by Region, Through 2028
Table 18: North American Market for Insulin Pens, by End User, Through 2028
Table 19: European Market for Insulin Pens, by End User, Through 2028
Table 20: Asia-Pacific Market for Insulin Pens, by End User, Through 2028
Table 21: Rest of the World Market for Insulin Pens, by End User, Through 2028
Table 22: Top Pharma Companies’ ESG Risk Ratings
Table 23: Novo Nordisk A/S: Key Environmental Performance Indicators, 2020-2022
Table 24: Novo Nordisk A/S: Key Social Performance Indicators, 2020-2022
Table 25: Novo Nordisk A/S: Key Governance Performance Indicators, 2020-2022
Table 26: Global Market Share of Insulin Pens, by Company, 2022
Table 27: Global Market Shares of Insulin Pens, by Product, 2022
Table 28: Global Insulin Market, Product Sales Revenue, 2020-2022
Table 29: Global Diabetes Treatment Market, Selected Recent Key Developments, September 2019-August 2022
Table 30: AstraZeneca: Company Snapshot
Table 31: AstraZeneca: Diabetology Product Information
Table 32: AstraZeneca: Revenue, 2020-2022
Table 33: AstraZeneca: Recent Key Developments, 2021-2023
Table 34: Biocon: Company Snapshot
Table 35: Biocon: Diabetology Product Information
Table 36: Biocon: Revenue, 2020-2022
Table 37: Biocon: Key Developments, 2021-2023
Table 38: Boehringer Ingelheim International GmbH: Company Snapshot
Table 39: Boehringer Ingelheim International GmbH: Diabetology Product Information
Table 40: Boehringer Ingelheim International GmbH: Annual Revenue, 2020-2022
Table 41: Boehringer Ingelheim International GmbH: Key Developments, 2019-2021
Table 42: Eli Lilly and Co.: Company Snapshot
Table 43: Eli Lilly and Co: Diabetology Product Information
Table 44: Eli Lilly and Co: Annual Revenue, 2020-2022
Table 45: Eli Lilly and Co: Recent Key Developments, 2020-2022
Table 46: Johnson & Johnson Services Inc.: Company Snapshot
Table 47: Johnson & Johnson Services Inc.: Diabetology Product Information
Table 48: Johnson & Johnson Services Inc.: Annual Revenue, 2020-2022
Table 49: Merck & Co. Inc.: Company Snapshot
Table 50: Merck & Co. Inc.: Diabetology Product Information
Table 51: Merck & Co. Inc.: Financials, 2020-2022
Table 52: Merck & Co. Inc.: Key Developments, 2021
Table 53: Novartis AG: Company Snapshot
Table 54: Novartis AG: Diabetology Product Information
Table 55: Novartis AG: Financials, 2020-2022
Table 56: Novartis AG: Key Developments, 2023
Table 57: Novo Nordisk A/S: Company Snapshot
Table 58: Novo Nordisk A/S: Diabetology Product Information
Table 59: Novo Nordisk A/S: Revenue, 2020-2022
Table 60: Novo Nordisk A/S: Recent Developments, 2019-2022
Table 61: Sanofi: Company Snapshot
Table 62: Sanofi: Business Segment
Table 63: Sanofi: Diabetology Product Information
Table 64: Sanofi: Annual Revenue, 2020-2022
Table 65: Sanofi: Key Developments, 2021-2023
Table 66: Viatris Inc.: Company Snapshot
Table 67: Viatris Inc.: Annual Revenue, 2020-2022
Table 68: Viatris Inc.: Diabetology Product Information
Table 69: Major Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Insulin Pens, by Type, 2020-2028
Summary Figure B: Global Market Shares of Insulin Pens, by Type, 2022
Figure 1: Market Dynamics for the Global Insulin Pens Market
Figure 2: Global Market Shares of Insulin Pens, by Region, 2022
Figure 3: North American Market Shares of Insulin Pens, by Type, 2022
Figure 4: European Market Shares of Insulin Pens, by Type, 2022
Figure 5: Asia-Pacific Market Shares of Insulin Pens, by Type, 2022
Figure 6: Rest of the World Market Shares of Insulin Pens, by Type, 2022
Figure 7: Global Market Shares of Insulin Pens, by Onset Time, 2022
Figure 8: Global Market Shares of Long-Acting Insulin Pens, by Region, 2022
Figure 9: Global Market Shares of Intermediate-Acting Insulin Pens, by Region, 2022
Figure 10: Global Market Shares of Short-Acting Insulin Pens, by Region, 2022
Figure 11: Global Market Shares of Rapid-Acting Insulin Pens, by Region, 2022
Figure 12: North American Market Shares for Insulin Pens, by End User, 2022
Figure 13: European Market Shares for Insulin Pens, by End User, 2022
Figure 14: Asia-Pacific Market Shares for Insulin Pens, by End User, 2022
Figure 15: Rest of the World Market Shares for Insulin Pens, by End User, 2022
Figure 16: Global Market Shares of Insulin Pens, by Company, 2022
Figure 17: Global Market Shares of Insulin Pens, by Product, 2022
Figure 18: Global Insulin Market, by Product, Sales Revenue, 2022
Figure 19: AstraZeneca: Revenue Share, by Country, 2022
Figure 20: Merck & Co. Inc.: Annual Revenue, by Segment, 2020-2022
Figure 21: Novartis AG: Innovative Medicine, Market Share, by Region, 2022
Figure 22: Novartis AG: Market Share, by Region, 2022
Figure 23: Sanofi: Annual Revenue, by Region, 2022
Figure 24: Sanofi: Revenue, by Segment, 2022
Figure 25: Viatris Inc.: Sales Share, by Region, 2022
